Caseware UK (AP4) 2023.0.135 2023.0.135 2024-02-292024-02-29true2023-03-01No description of principal activity22truefalse 07941586 2023-03-01 2024-02-29 07941586 2022-03-01 2023-02-28 07941586 2024-02-29 07941586 2023-02-28 07941586 c:Director1 2023-03-01 2024-02-29 07941586 d:CurrentFinancialInstruments 2024-02-29 07941586 d:CurrentFinancialInstruments 2023-02-28 07941586 c:EntityNoLongerTradingButTradedInPast 2023-03-01 2024-02-29 07941586 c:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 07941586 c:FullAccounts 2023-03-01 2024-02-29 07941586 c:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 07941586 c:Micro-entities 2023-03-01 2024-02-29 07941586 e:PoundSterling 2023-03-01 2024-02-29 iso4217:GBP xbrli:pure
Registered number: 07941586











________________________________________________________________________________________


NUCLEUS HEALTHCARE HOLDINGS LIMITED

________________________________________________________________________________________



UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 
29 FEBRUARY 2024

 
NUCLEUS HEALTHCARE HOLDINGS LIMITED
REGISTERED NUMBER:07941586

BALANCE SHEET
AS AT 29 FEBRUARY 2024

29 February
28 February
2024
2023
£
£


Creditors: amounts falling due within one year
(994,646)
(994,646)

Net current liabilities
 
 
(994,646)
 
 
(994,646)

Total assets less current liabilities
(994,646)
(994,646)


Net liabilities
(994,646)
(994,646)



Capital and reserves
(994,646)
(994,646)


Notes


General information

Nucleus Healthcare Holdings Limited is registered in England and Wales and its registered number is 07941586. The Company is a private company limited by shares. Its registered office is 15 Whitehall, London, SW1A 2DD.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


Directors' confirmations

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 31 October 2024.




B. C. Palmer
Director

Page 1